# 1. Financial Performance ## A. Key Figures * **Sales:** **3%** H1 growth (despite tariffs, GST, monsoon) · **EBITDA:** **4%** increase * **PAT:** **~150%** increase (due to currency loss base effect) * **BOPET Margin:** **20%** gross (India, base film) · **BOPP Margin:** **30%** * **Debt:** **₹1,500 Cr** outstanding, to reduce by **₹500 Cr** by **Mar-27** ## B. Revenue & Profit * **Exceptional Bottom-Line Growth:** PAT surged on low base from prior-year currency losses, while top-line and EBITDA showed resilient growth amid macro headwinds. * **Cost Discipline Focus:** Management implementing efficiency measures to support profitability, though specific initiatives remain undisclosed. ## C. Margins Trend * **Strong Margin Recovery:** BOPET and BOPP margins expanded significantly on improved pricing power and reduced import competition. * **Sustainable Margin Culture:** Margin improvement driven by ongoing operational rigor, not one-off actions, with tight control on **manpower costs** despite project delays. * **Strategic Prioritization:** Focus remains on topline growth and structural margin enhancement over minor austerity measures. ## D. Balance Sheet * **Deleveraging Trajectory:** Clear path to reduce debt by **₹500 Cr** by FY'27, signaling disciplined capital structure management. --- # 2. Volume & Utilization ## A. Key Figures * Aseptic Packaging Volume: 5.5% YoY H1 · 12 billion packs/year expanded capacity (Oct commissioning) * Sales Volume: **+5.4%** YoY H1, with seasonal Q2 dip * **Packaging Film Production Volume:** **–6%** YoY overall * **Plant Utilization:** **136%** Q1 → **99%** Q2 (liquid packaging), despite **50% capacity increase** ## B. Production Volume * **Record Aseptic Performance:** Strong double-digit growth momentum in aseptic packaging underpinned by capacity expansion and resilient demand, with full benefit expected from Q4 FY'26 onward. * **Mixed Packaging Film Trends:** Overall production volume decline masked regional divergence, with **Mexico showing positive growth** and stable profitability, while domestic film operations faced headwinds. * **Regional Demand Catalyst:** BOPP expansion driven by supply gap in South India, where only one production line currently exists, creating logistical inefficiencies. ## C. Plant Utilization * **Seasonal Utilization Swing:** Sharp drop in liquid packaging plant utilization from Q1 to Q2 reflects typical seasonal demand lull, not structural weakness, with management confident in **sustained 100% utilization** over the cycle. * **Export Limitations:** Seasonal demand in Europe and North America restricts export arbitrage opportunities to absorb domestic off-season idle capacity. * **Recycling Plant Ramp-Up:** Commissioned in March, recycling plant is expected to achieve **strong utilization starting next fiscal**, adding incremental operational leverage. * **Geographic Utilization Divergence:** Utilization improved in India and Dubai, while Egypt, Poland, and Hungary lag; Nigeria rebounded QoQ despite slight YoY decline. ## D. Capacity Additions * **Strategic BOPP Expansion:** Two new BOPP plants to come online by FY'27, with a third **Rs. 750 Cr** project targeting FY'28, reinforcing leadership in a supply-constrained region. * **BOPET Growth Optionality:** One new BOPET plant expected by FY'28, with potential for further additions as a key global player exits the market, driving import dependency. * **Dharwad Commitment:** New **54,000 TPA** BOPP line fulfills state-level investment obligations and strengthens South India footprint. --- # 3. Product & Segment Mix ## A. Key Figures * **BOPP Margins:** **~30%** (favorable) · **BOPET Margins:** **~20%** (less favorable) * **Capacity Mix:** **31,200 tons** BOPP capacity · **110,000 tons** BOPET capacity (India) ## B. BOPP vs BOPET * **Adverse Product Mix:** The company faces structural margin headwinds due to dominant exposure to lower-margin BOPET, in contrast to peers with higher BOPP capacity. * **Competitive Disadvantage:** Cosmo First’s superior financial performance was amplified by favorable market conditions during BOPP supply shortages and timely capacity ramp-up. * **Segment Shift:** Film businesses historically focused on packaging films; current profitability and valuation reflect evolved market dynamics beyond legacy benchmarks. ## C. Recycling Business * **Near-Term Demand Risk:** Recycling plant order visibility weakened due to government deferral of recycled content compliance to FY'26, prompting brands to delay fulfillment. * **FY'27 Inflection Expected:** Demand for recycled PET is projected to surge in FY'27 as brand owners must meet both deferred FY'26 obligations and current-year EPR targets, with **no compliance exemptions** allowed. --- # 4. Demand & Pricing ## A. Key Figures * **BOPET Exports:** **Down 18%** QoQ (production disruption) * **BOPP Exports:** **Down 22%** QoQ (production disruption) ## B. Import Impact * **Export Disruptions:** Sharp decline in Indian BOPET and BOPP exports due to fire-related production outages at a key regional player. * **Tariff Pressure:** U.S.-bound exports face sustained margin pressure from a **25% additional oil-related tariff**, with **50% of the cost still absorbed internally** despite partial pass-through. ## C. Seasonal Demand * **Demand Lag:** B2B print order delays in India linked to GST-driven MRP compliance, prompting customers to deplete inventory before placing new orders. ## D. Price Recovery * **Supply-Tight Markets:** BOPP continues to face structural shortages, supporting price resilience and no near-term relief. * **Input Cost Tailwinds:** Relaxation of BIS rules enables cheaper raw material imports, potentially lowering input costs for packaging and film producers. --- # 5. Capital & Funding ## A. Key Figures * **Additional Debt Requirement:** **₹950 Cr** for ongoing projects by FY'27 · **~₹1,000 Cr** new debt expected in FY'27 * **Net Debt:** **₹7,750 Cr** current level · **₹7,300 Cr** projected by FY'27 (-₹500 Cr) * **EBITDA (Projected):** **₹2,500–2,600 Cr** in FY'27 * Debt/EBITDA Ratio: ~2.8x projected by FY'27; 2.5x deemed unfeasible ## B. Debt Strategy & Sustainability * **Elevated Leverage Path:** Debt-to-EBITDA expected to reach ~8x by FY'27 despite net debt reduction, raising questions about long-term capital structure sustainability. * **Interest Rate Flexibility:** Debt carries a floating rate that will automatically benefit from declines in dollar or domestic rates, reducing need for active loan restructuring. * **Funding Prioritization:** Management intends to preserve balance sheet cash for strategic investments, signaling cautious approach to incremental borrowing. ## C. Equity Fundraising Prospects * **Public Market Challenges:** Despite strong overall IPO market activity, equity raising at the parent level is unlikely due to promoter ownership structure and weakened international EBITDA. * **Global Headwinds Impacting Appetite:** Decline in international EBITDA—driven by currency devaluation (e.g., Nigeria) and operational challenges—has dampened investor confidence for listing efforts. * **Subsidiary-Level Option Remote:** While discussions with US bankers continue, equity fundraising at subsidiary level remains a theoretical possibility with no near-term expectations. ## D. Project Financing * **State Incentives Secured:** BOPP plant eligible for incentives under state investment policy upon meeting capital expenditure thresholds. --- # 6. Risks & Overcapacity ## A. Key Figures * **BOPET Imports:** +120% YoY in H1 FY'26 * **BOPP Imports:** +100% YoY in H1 FY'26 ## B. BOPET Overhang * **Strategic Capacity Rationalization:** Huhtamaki’s restructuring created a one-off market impact without competitive volume or pricing gains, as production consolidated into core facilities. * **Supply-Demand Cycles Drive Investment Timing:** Post-pandemic BOPET oversupply stemmed from high capacity utilization (>80%) and exceptional profits that fueled new investments, now leading to a two-year overcapacity outlook. * **Early-Mover Advantage Validated:** Company’s overseas plants (Nigeria, Hungary, Poland) achieved immediate profitability by investing during low-cycle periods, capturing gains from pandemic-driven supply imbalances. * **Long-Term Capacity Discipline:** Management views strategic expansion as a SIP-like approach—investing through cycles rather than timing markets—to maintain relevance amid industry-wide capacity additions. ## C. Import Competition * **Surge in Import Volumes:** Sharp year-on-year increases in BOPET and BOPP imports into India reflect rising import dependency and competitive pressure. * **Global Trade Disruptions:** U.S. tariffs redirected Chinese and Southeast Asian exports to Europe, exacerbating import-driven price competition and weighing on European performance in Q2. * **Margin Recovery Underway:** Import-related price pressure has eased, with domestic margins recovering and expected to improve further in the current quarter. * **Erosion of Import Economics:** PET importers are recognizing rapid domestic price adjustments, undermining import profitability and likely curbing future inflows. * **Broadening Polymer Import Threat:** Removal of BIS certification for POY, PSF, PTA, and MEG has lowered entry barriers, increasing import competition and threatening domestic polymer producers. ## D. Regulatory Shifts * **Extended Recycling Compliance Window:** Brand owners now have three years to meet FY'26 recycling obligations due to infrastructure gaps, reducing near-term regulatory pressure. * **Duty Protection Unlikely:** No segment is currently in severe distress, making anti-dumping duties improbable despite import surges. * **Regulatory Liberalization Trend:** Recent removal of polymer items from QCO signals a broader shift toward reduced import controls, though duty implications remain unclear. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth Guidance:** **5%** (revised down from 10%) * **EBITDA Guidance:** **₹1,800–1,850 Cr** (revised down from ₹2,000–2,100 Cr) · **~₹1,700 Cr** prior year * **New Project Contribution:** **~₹3,000 Cr** top-line · **~₹500 Cr** EBITDA at full run-rate ## B. Revenue Forecast * **Downward Revision Reflects H1 Headwinds:** Full-year revenue growth guidance cut to low-single digits due to challenging market conditions, despite initial 10% target. * **Next-Year Outlook Cautiously Constructive:** Management anticipates **10% revenue growth** pending timely project commissioning, though formal guidance is deferred. * **Demand Tailwinds Emerging:** GST transition completion and recent tax cuts expected to boost **consumer demand**, supporting packaging sector recovery. ## C. EBITDA Projection * **EBITDA Guidance Revised Lower but Still Up YoY:** Despite downward revision, EBITDA outlook reflects **modest year-on-year improvement**, pressured by transition costs in H1. * **Structural Leverage Expected from FY'27:** New capacities coming online on a largely settled debt base to drive **meaningful EBITDA expansion** starting FY'27. ## D. Commissioning Timeline * **Project Delays Push Full Ramp-Forward to Q1 FY'27:** Three of four major projects delayed; **recycling plant to start by March**, while WPP and Egypt aseptic likely extend into **Q1 FY'27**. * **One Facility Already Live:** India aseptic line is **operational**, providing early traction for new capacity rollout. * **Near-Term Trade Relief Expected:** **25% U.S. oil export duty** anticipated to be waived imminently, removing a key near-term cost overhang. * **Long-Term Trade Uncertainty Persists:** Global tariff shifts, especially U.S. policy, remain a **key risk** to export volumes and margins.